AlphaYouJG
Congress trade
Rep. Josh Gottheimer (D-NJ) sold $1K-$15K of Abbott Laboratories (ABT) stock
Josh Gottheimer, U.S. Representative (D-NJ), disclosed a sale of Abbott Laboratories (ABT) stock worth $1K-$15K in a STOCK Act filing on Apr 10, 2025.
The trade happened on Mar 6, 2025, 35 days before it was made public.
ABT has moved -27.8% since the trade date, from $135.08 to $97.50 (Oct 2, 2026 close).
- Traded
- Mar 6, 2025
- Disclosed
- Apr 10, 2025
- Filing delay
- 35 days
- Price since
- -27.8%
- Source
- STOCK Act disclosure
Other trades in this disclosure (47)
- SellAAPL$1K-$15KApr 10, 2025
- SellAAPL$1K-$15KApr 10, 2025
- SellAPD$1K-$15KApr 10, 2025
- BuyAPP$1K-$15KApr 10, 2025
- BuyASML$1K-$15KApr 10, 2025
- SellAVGO$1K-$15KApr 10, 2025
- SellAZTA$1K-$15KApr 10, 2025
- SellBBVA$1K-$15KApr 10, 2025
- BuyBKNG$1K-$15KApr 10, 2025
- BuyBKNG$1K-$15KApr 10, 2025
- SellCHRD$1K-$15KApr 10, 2025
- SellCRNX$1K-$15KApr 10, 2025
- BuyDASH$1K-$15KApr 10, 2025
- SellDAVA$1K-$15KApr 10, 2025
- SellDEO$1K-$15KApr 10, 2025
- SellDHI$1K-$15KApr 10, 2025
- SellDSCSY$1K-$15KApr 10, 2025
- BuyFI$1K-$15KApr 10, 2025
- SellFLYW$1K-$15KApr 10, 2025
- BuyGILD$1K-$15KApr 10, 2025
More ABT insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.